Prediabetes Market: By Drug Class (Diguanide, SGLT2 Inhibitors, Thiazolidinediones, Glucagon-like Peptide-1 Agonists (GLP-1), DPP-4 Inhibitors, Others); Age Group (Children (12-18 years), Adults (18-49), Elderly (50+)) Region—Market Size, Industry Dynamics, Opportunity Analysis and Forecast for 2025–2033
Prediabetes market was valued at US$ 322.14 million in 2024 and is projected to hit the market valuation of US$ 599.34 million by 2033 at a CAGR of 7.15% during the forecast period 2025–2033. Read More
We Are Trusted By These Great Companies!
Last Updated: 05-Feb-2025 | Format: | Report ID: AA02251151